This report was first published by Endpoints News. To see the original version, click here
Now Eli Lilly has an obesity pill, too.
On Wednesday, the FDA approved orforglipron, the agency announced. It will be sold as Foundayo, and Lilly has previously said it plans to sell a starting dose for $149 a month and higher doses for up to $349 a month.
您已阅读7%（345字），剩余93%（4924字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。